Introduction:
Osteoporosis is a common condition in adults, causing degenerative bony changes such as reduced bone mass and changes in bone structure, which makes the bone fragile and increases the risk of a bone fracture. This is commonly seen in adults diagnosed with rheumatoid arthritis (a type of chronic inflammatory disease affecting the joints) and can heighten the likelihood of experiencing fractures. When patients suffer fractures, they often face prolonged periods of immobilization, which can further negatively impact bone health.
Numerous studies have indicated an increase in osteoporosis among individuals with rheumatoid arthritis compared to those of the same age and gender without rheumatoid arthritis. Various factors contribute to this elevated risk, such as challenges in engaging in physical activity and prolonged usage of corticosteroids. Therefore, it is important to note that while rheumatoid arthritis is a contributing factor, osteoporosis can also occur due to other causes. Therefore, when diagnosing osteoporosis in any patient, it is crucial to conduct the necessary and standard tests to rule out alternative explanations.
What Is Osteoporosis?
Osteoporosis is derived from the term porous bone, which represents a skeletal condition characterized by diminished bone quantity and quality. Peak development of bone mass typically occurs around the age of thirty and gradually diminishes thereafter. Bones undergo a continual process of breakdown and rebuilding, with approximately ten percent of the adult skeleton being remodeled each year. When there is an imbalance between the rates of breakdown and formation, bone loss occurs, resulting in fragile bones and an elevated risk of fractures. The hip, spine, and wrist are among the most common sites for fractures related to osteoporosis.
What Is the Prevalence of Osteoporosis?
Osteoporosis affects a significant number of individuals in the United States, with estimates exceeding 50 million people living with the condition. Among individuals aged 50 and above, osteoporosis is notably prevalent. Experts suggest that approximately half of females and one in four males at birth who are over 50 years old are affected by osteoporosis. Studies indicate that about one in three adults aged over 50 who have not yet been diagnosed with osteoporosis exhibit some level of reduced bone density, known as osteopenia. Osteopenia is considered an early indicator of osteoporosis. If left untreated, osteopenia can progress to osteoporosis.
Why Are Individuals With Rheumatoid Arthritis More Prone to Osteoporosis?
Rheumatoid arthritis (RA) can impact bone structure by damaging the joints, known as erosions, and lead to the development of osteoporosis. The causes of osteoporosis linked with rheumatoid arthritis are multiple, such as chronic inflammation effects, medication influences, and lifestyle factors.
Some of the most commonly reported rheumatoid arthritis-related risk factors include inflammation, disease duration, immobility, disability, and high-dose corticosteroid use. Additionally, there exist several traditional risk factors unrelated to rheumatoid arthritis, such as female gender, advancing age, postmenopausal state, family history of osteoporosis, being underweight, insufficient physical activity, smoking, excessive alcohol consumption, and increased risk of falling.
How Is Osteoporosis Diagnosed?
The diagnosis of osteoporosis involves assessing bone density through a scan known as dual-energy X-ray absorptiometry or DEXA. DEXA serves as the standard method for confirming or establishing an osteoporosis diagnosis. This imaging technique utilizes low levels of radiation, offering a quick procedure that does not require the patient to undress or be enclosed, making it suitable for individuals who experience claustrophobia. The scan results can be input into an online tool named FRAX, enabling the calculation of the possibility of the patient experiencing a bone fracture within the next decade.
Patients concerned about their potential risk of osteoporosis can initiate discussions with their healthcare professional to seek further guidance. In certain scenarios where the risk of an osteoporotic fracture is considered high, treatment may be initiated without the necessity of a DEXA scan. Although an initial scan is commonly performed and beneficial, follow-up scans are less frequently recommended nowadays. However, where necessary, these follow-ups typically occur every three to five years. Consulting with a hospital professional can provide clarity on the need for such follow-up scans.
What Are the Management Strategies for Osteoporosis in Rheumatic Patients?
Osteoporosis can be managed by educating the patient about all the risk factors and complications related to it along with that, the patient has to make certain lifestyle changes, including taking a healthy diet or vitamin D-rich diet or doing weight-bearing exercises and exposure to sunlight. Some of the common management strategies for osteoporosis include:
1. Pharmacological Interventions:
Bisphosphonates: Bisphosphonates, such as Alendronate and Risedronate, are commonly used to treat osteoporosis. However, their use in rheumatic patients, especially those on long-term steroid therapy, should be carefully monitored due to the potential risk of osteonecrosis (bone death due to no blood supply).
Calcium and Vitamin D Supplementation: Sufficient calcium and vitamin D intake helps in maintaining bone health. Rheumatic patients, particularly those with limited sun exposure or malabsorption issues, may require supplementation to achieve optimal levels.
Biologic Therapies: Some biologic agents used in the treatment of rheumatic diseases have shown beneficial effects on bone health. For instance, TNF-alpha inhibitors have demonstrated a reduction in bone resorption markers in rheumatoid arthritis patients. However, further research is needed to elucidate their long-term effects on bone density.
2. Lifestyle Modifications:
Exercise: Weight-bearing exercises, resistance training, and balance exercises can assist in improving bone density and muscle strength, therefore lowering the risk of falls and fractures.
Nutrition: Sufficient consumption of calcium and vitamin D intake is crucial for maintaining bone health. Supplements may be necessary, especially in patients with malabsorption or those on corticosteroids.
3. Managing Fracture Risk:
Assessing individual fracture risk using tools like FRAX (fracture risk assessment tool) can guide the initiation and monitoring of treatment.
Fall prevention strategies, including home modifications, balance training, and minimizing environmental hazards, are crucial in reducing fracture risk in rheumatic patients with osteoporosis.
4. Monitoring and Follow-Up: Regular monitoring by using bone mineral density tests and fracture risk, along with assessing the efficacy and safety of prescribed medications, is essential in the long-term management of osteoporosis in rheumatic patients. Adjustments in treatment strategies should be made based on individual patient responses and changes in disease activity.
Conclusion:
The management of osteoporosis in rheumatic patients requires a multidisciplinary approach, integrating rheumatology, orthopedics, and bone health expertise. It involves a combination of lifestyle modifications, pharmacological interventions, and optimal control of the underlying rheumatic disease. Personalized treatment strategies and regular monitoring play pivotal roles in mitigating the risk of fractures and improving the overall quality of life for these individuals.
